Medtronic’s Extravascular ICD Meets Efficacy and Safety Criteria for Global Pivotal Clinical Trial

Late-breaking data presented at the ESC 2022 Congress and simultaneously published in The New England Journal of Medicine confirms the safety of the implantation procedure and the success of the defibrillation DUBLIN and BARCELONA, Spain, August 28, 2022 /CNW/ – Medtronic plc (NYSE: MDT), a global health technology leader, today announced that its investigational EV …

Medtronic’s Extravascular ICD Meets Efficacy and Safety Criteria for Global Pivotal Clinical Trial Read More »